These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31217270)

  • 41. Evaluation of the Bio-Rad Geenius HIV 1/2 Assay as Part of a Confirmatory HIV Testing Strategy for Quebec, Canada: Comparison with Western Blot and Inno-Lia Assays.
    Serhir B; Desjardins C; Doualla-Bell F; Simard M; Tremblay C; Longtin J
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection.
    Curtis KA; Rudolph DL; Pan Y; Delaney K; Anastos K; DeHovitz J; Kassaye SG; Hanson CV; French AL; Golub E; Adimora AA; Ofotokun I; Bolivar H; Kempf MC; Peters PJ; Switzer WM
    PLoS One; 2021; 16(7):e0242641. PubMed ID: 34197451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection.
    Karris MY; Anderson CM; Morris SR; Smith DM; Little SJ
    J Clin Microbiol; 2012 Jun; 50(6):1874-8. PubMed ID: 22442319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.
    Stone M; Bainbridge J; Sanchez AM; Keating SM; Pappas A; Rountree W; Todd C; Bakkour S; Manak M; Peel SA; Coombs RW; Ramos EM; Shriver MK; Contestable P; Nair SV; Wilson DH; Stengelin M; Murphy G; Hewlett I; Denny TN; Busch MP
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.
    Jensen TO; Robertson P; Whybin R; Chambers I; Lahra M; Rawlinson W; Post JJ
    J Clin Microbiol; 2015 May; 53(5):1709-11. PubMed ID: 25673794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of the Signal-to-Cutoff Ratio and Antigen Index from Fourth- and Fifth-Generation HIV-1/HIV-2 Antigen/Antibody Assays for the Diagnosis of Acute HIV Infection: Applicability for Real-Time Use for Immediate Initiation of Antiretroviral Therapy.
    Whitney E; Pitrak D; Beavis KG; Moore NM; Shankaran S; Abeleda AP; Schmitt J; Sha BE
    J Clin Microbiol; 2022 Dec; 60(12):e0120422. PubMed ID: 36448814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays.
    Fogel JM; Piwowar-Manning E; Debevec B; Walsky T; Schlusser K; Laeyendecker O; Wilson EA; McCauley M; Gamble T; Tegha G; Soko D; Kumwenda J; Hosseinipour MC; Chen YQ; Cohen MS; Eshleman SH
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):426-430. PubMed ID: 28471839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of Abbott Fourth Generation HIV Antigen and Antibody Assays.].
    Kang HJ; Yoo KH; Kim HS; Cho HC
    Korean J Lab Med; 2006 Feb; 26(1):39-44. PubMed ID: 18156698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for Human Immunodeficiency Virus Infection by Use of a Fourth-Generation Antigen/Antibody Assay and Dried Blood Spots: In-Depth Analysis of Sensitivity and Performance Assessment in a Cross-Sectional Study.
    Stefic K; Guinard J; Peytavin G; Saboni L; Sommen C; Sauvage C; Lot F; Laperche S; Velter A; Barin F
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroconversion, seroreversion, and serowaffling among participants initiating antiretroviral therapy in Project DETECT.
    Stekler JD; Violette LR; Niemann LA; McMahan VM; Katz DA; Chavez PR; Clark HA; Cornelius-Hudson A; McDougal SJ; Delaney KP
    Int J STD AIDS; 2023 May; 34(6):385-394. PubMed ID: 36703607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Broadly neutralizing HIV-1 antibody reactivity in HIV tests: implications for diagnostics.
    Smith T; Masciotra S; Luo W; Sullivan V; Switzer WM; Johnson JA; Heneine W
    AIDS; 2021 Aug; 35(10):1561-1565. PubMed ID: 33756512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation in a clinical setting of the performances of a new rapid confirmatory assay for HIV1/2 serodiagnosis.
    Abbate I; Pergola C; Pisciotta M; Sciamanna R; Sias C; Orchi N; Libertone R; Ippolito G; Capobianchi MR
    J Clin Virol; 2014 Sep; 61(1):166-9. PubMed ID: 25037532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Could HIV-1 RNA Testing be an Option as the Second Step in the HIV Diagnostic Algorithm?
    Masciotra S; Luo W; Rossetti R; Smith T; Ethridge S; Delaney KP; Wesolowski LG; Owen SM
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S26-S31. PubMed ID: 31977972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays.
    Suligoi B; Rodella A; Raimondo M; Regine V; Terlenghi L; Manca N; Casari S; Camoni L; Salfa MC; Galli C
    J Clin Microbiol; 2011 Jul; 49(7):2610-3. PubMed ID: 21543577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance evaluation of the ADVIA Centaur(®) HIV Ag/Ab Combo assay.
    Pumarola T; Freeman J; Saxton E; Dillon P; Bal T; van Helden J
    J Virol Methods; 2010 Dec; 170(1-2):16-20. PubMed ID: 20723562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of Two Anti-HIV Confirmatory Assays: Recombinant HIV 1/2 Line Immunoassay and Geenius HIV 1/2 Confirmatory Test].
    Zeytinoğlu A; Kayın M; Altuğlu İ; Gökengin D; Sertöz R
    Mikrobiyol Bul; 2020 Oct; 54(4):613-618. PubMed ID: 33107290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performances of four fourth-generation human immunodeficiency virus-1 screening assays.
    Song EY; Hur M; Roh EY; Park MH; Moon HW; Yun YM
    J Med Virol; 2012 Dec; 84(12):1884-8. PubMed ID: 23080491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative evaluation of the Geenius HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population.
    Kondo M; Sudo K; Sano T; Kawahata T; Itoda I; Iwamuro S; Yoshimura Y; Tachikawa N; Kojima Y; Mori H; Fujiwara H; Hasegawa N; Kato S
    PLoS One; 2018; 13(10):e0198924. PubMed ID: 30379808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of a new vesion of the human immunodeficiency virus antigen and antibody combination assay with improved sensitivity in HIV-1 p24 antigen detection].
    Sano T; Kondo M; Yoshimura Y; Tachikawa N; Sagara H; Itoda I; Yamanaka K; Sudo K; Kato S; Imai M
    Kansenshogaku Zasshi; 2013 Jul; 87(4):415-23. PubMed ID: 23984590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.